Caricamento...
The Aryl Hydrocarbon Receptor (AhR) as a Drug Target for Cancer Chemotherapy
The aryl hydrocarbon receptor (AhR) is overexpressed in some patients with different tumor types, and the receptor can be a negative or positive prognostic factor. There is also evidence from both in vivo and in vitro cell culture models that the AhR can exhibit tumor-specific pro-oncogenic and tumo...
Salvato in:
| Pubblicato in: | Curr Opin Toxicol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5407490/ https://ncbi.nlm.nih.gov/pubmed/28459113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cotox.2017.01.012 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|